NA Proactive news snapshot: Todos, Globex Mining, Falcon Gold Corp, Water Tower Research, Appia Rare Earths & Uranium UPDATE …

Your daily round-up from the world of Proactive Todos Medical Ltd majority-owned subsidiary 3CL Pharma Ltd has reported a Day 26 update from an ongoing 60-day case study of the dietary supplement 3CL protease inhibitor Tollovid in a patient experiencing symptoms of long COVID. The patient, a 33-year-old man, originally contracted COVID-19 in March 2021 and experienced persistent long COVID symptoms, including significant weight loss, nausea and fatigue, the company said. On May 5, he began a regimen of 12 Tollovid Maximum Strength capsules for five days, and symptoms significantly improved. Digestion and heart rate returned to the patient’s pre-COVID baseline and he reported improvements in brain fog as well as better sleep, although a sleep monitor still noted less sleep.

Globex Mining Enterprises Inc said underground exploration at the Labyrinth gold project in Quebec is approaching completion, with initial results supporting a potentially significant Joint Ore Reserves Committee (JORC) […]

About the author: StockMan
Tell us something about yourself.
Posting Guidelines
  • Do contribute something to the discussion
  • Do post factual information, analysis and your view on company valuations
  • Do disclose if you have an interest in a security
  • Do take our Terms of Use seriously
Do Not
  • Do not make low-content posts, unsubstantiated ramps or untruthful/misleading statements
  • Do not complain about a post unless you have reported it first, and not on the forum.
  • Do not post financial advice
  • Do not advertise or post sponsored content

Get involved!

Get Connected!

Come and join our community. Expand your network and get to know new people!


No comments yet